Follow The Filings

ASMB Assembly Biosciences

Assembly Biosciences earnings company data as of 7:04 PM ET 11/19

  • 1 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS -0.49 GAAP -0.93 —
Rev — — —
FY2026 Q2 13 Aug EPS -0.53 -0.20 Beat
Rev — $13.4M —

Insider trades

Open-market buys and sales by ASMB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ASMB insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 16 stock grants and 13 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K/A 2.02,9.01
SCHEDULE 13G/A —
8-K 2.01,9.01
10-Q
SCHEDULE 13G/A —
8-K 5.02,5.07,9.01
SCHEDULE 13D/A —
424B5
8-K 1.01,8.01,9.01
8-K 7.01,8.01,9.01
424B5
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf